Loading clinical trials...
Loading clinical trials...
This study is to provide safety information of hemoporfin during the post-marketing period as required by China Food and Drug Administration (CFDA) regulations in order to identify any potential drug ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
NCT05171894 · Port-wine Birthmarks, Port-Wine Stain, and more
NCT04336163 · Port-Wine Stain, Rosacea, and more
NCT05771311 · Port-Wine Stain
NCT00667472 · Port-Wine Stain
NCT00540917 · Port-Wine Stain
The 2nd Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang
Affiliated Hospital of Hebei Medical College of traditional Chinese Medicine
Shijiazhuang, Herbei
Wuxi People's Hospital
Wuxi, Jiangsu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions